Axonal amyloid precursor protein and its fragments undergo somatodendritic endocytosis and processing

Autor: Emily D. Niederst, Sol M. Reyna, Lawrence S.B. Goldstein
Přispěvatelé: Forscher, Paul
Rok vydání: 2015
Předmět:
Aging
Cellular differentiation
Neurodegenerative
Inbred C57BL
Alzheimer's Disease
Medical and Health Sciences
Mice
Amyloid beta-Protein Precursor
Amyloid precursor protein
2.1 Biological and endogenous factors
Aetiology
Cells
Cultured

Mice
Knockout

Benzodiazepinones
Microscopy
Microscopy
Confocal

Cultured
biology
Cell Differentiation
Articles
Microfluidic Analytical Techniques
Biological Sciences
Endocytosis
Cell biology
Biochemistry
Cell Biology of Disease
Confocal
Neurological
Signal transduction
Oligopeptides
Signal Transduction
Cells
Knockout
1.1 Normal biological development and functioning
Cell Line
Underpinning research
mental disorders
Acquired Cognitive Impairment
Animals
Humans
Secretion
Molecular Biology
Embryonic Stem Cells
Amyloid beta-Peptides
Hydrazones
Neurosciences
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Cell Biology
Dendrites
Embryonic stem cell
Axons
Peptide Fragments
Brain Disorders
Mice
Inbred C57BL

Somatodendritic compartment
Luminescent Proteins
nervous system
biology.protein
Dementia
Amyloid Precursor Protein Secretases
Amyloid precursor protein secretase
Developmental Biology
Zdroj: Molecular biology of the cell, vol 26, iss 2
Molecular Biology of the Cell
Popis: In mouse and human neurons, axonally secreted amyloid precursor protein (APP) fragments are processed in the cell body before being sorted into the axon in a process that requires endocytosis for the processing, but not axonal delivery, of APP.
Deposition of potentially neurotoxic Aβ fragments derived from amyloid precursor protein (APP) at synapses may be a key contributor to Alzheimer's disease. However, the location(s) of proteolytic processing and subsequent secretion of APP fragments from highly compartmentalized, euploid neurons that express APP and processing enzymes at normal levels is not well understood. To probe the behavior of endogenous APP, particularly in human neurons, we developed a system using neurons differentiated from human embryonic stem cells, cultured in microfluidic devices, to enable direct biochemical measurements from axons. Using human or mouse neurons in these devices, we measured levels of Aβ, sAPPα, and sAPPβ secreted solely from axons. We found that a majority of the fragments secreted from axons were processed in the soma, and many were dependent on somatic endocytosis for axonal secretion. We also observed that APP and the β-site APP cleaving enzyme were, for the most part, not dependent on endocytosis for axonal entry. These data establish that axonal entry and secretion of APP and its proteolytic processing products traverse different pathways in the somatodendritic compartment before axonal entry.
Databáze: OpenAIRE